LAVI — Lavipharm SA Cashflow Statement
0.000.00%
Last trade - 00:00- €144.37m
- €168.33m
- €50.93m
- 62
- 17
- 73
- 48
Annual cashflow statement for Lavipharm SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.12 | 3.38 | 2.75 | 2.14 | 3.13 |
| Depreciation | |||||
| Non-Cash Items | 3.16 | 3.54 | 4.17 | 4.8 | 1.68 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.81 | -5.63 | -4.74 | -5.3 | -8.87 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.89 | 2.85 | 3.82 | 3.35 | 0.284 |
| Capital Expenditures | -2.42 | -1.48 | -1.92 | -35.6 | -4.12 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.008 | 0.004 | 0.034 | 0.026 | 0.659 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.41 | -1.47 | -1.88 | -35.6 | -3.46 |
| Financing Cash Flow Items | — | — | — | — | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.595 | -1.18 | -2.23 | 48.8 | -6.63 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.11 | 0.2 | -0.294 | 16.6 | -9.81 |